MCOV-B Medicover AB (publ)

25.49USD259.00 SEK · STO0.00%Mkt Cap: 3.87B USDP/E: 38.66

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services incl…

Institutional holders11 on file

Key Statistics

Company
Market Cap3.87B USD
Enterprise Value3.99B USD
Revenue (TTM)2.72B USD
Gross Profit604.01M USD
Net Income (TTM)85.00M USD
Revenue/Share17.98 USD
Last Price25.49 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees49.0K
CountrySE
SectorHealthcare
IndustryMedical Care Facilities
ISINSE0009778848
Valuation
P/E (Trailing)38.66
P/E (Forward)563.04
PEG—
EV/EBITDA141.61
EV/Revenue1.47
P/S15.86
P/B72.94
EPS (TTM)7.35 USD
EPS (Forward)0.50 USD
52W Range
17.6676% of range28.00
52W High28.00 USD
52W Low17.66 USD
Profitability
Gross Margin23.16%
Oper. Margin7.41%
EBITDA Margin11.54%
Profit Margin3.26%
ROE14.55%
ROA3.20%
ROIC6.07%
ROCE9.09%
Growth
Revenue Growth6.00%
Earnings Growth33.80%
Cash Flow & Leverage
Operating CF376.97M USD
CapEx (TTM)173.40M USD
FCF Margin2.31%
FCF Yield1.63%
Net Debt1.29B USD
Net Debt/EBITDA4.11
Net Debt/FCF20.50
Balance Sheet
Debt/Equity2.70
Current Ratio0.75
Quick Ratio0.34
Book Value/Sh3.89 USD
Cash/Share0.62 USD
Dividends
Fwd Div Rate0.21 USD
Trail. Div Rate0.02 USD
Div. Yield0.84%
5Y Avg Yield0.68%
Payout Ratio33.96%
Ex-Div DateApr 30, 2026
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.24 USD
Upside (mean)+10.8%
Target Range23.90 USD – 34.07 USD
23.90+10.8% to mean34.07
# Analysts8
Ownership
Shares Out.75.42M
Float53.13M
Insiders8.58%
Institutions45.55%
Technical
SMA 5025.79 (-1.2%)
SMA 20022.28 (+14.4%)
Beta1.51
S&P 52W Chg12.00%
Avg Vol (30d)77.64K
Avg Vol (10d)73.22K
Technical Indicators
RSI (14)40.4
MACD-1.4916
MACD Signal0.5300
MACD Hist.-2.0215
BB Upper28.14 USD
BB Middle26.49 USD
BB Lower24.85 USD
BB Width12.44%
ATR (14)0.5803 USD
Vol Ratio (20d)0.31x

About Medicover (STO: MCOV-B)

›

Medicover (STO: MCOV-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 49,000 employees.

The shares were at 259.00 SEK on 19 November 2026, up 6.9% over 52 weeks. Its 52-week range is 179.40 SEK to 284.50 SEK: the price is 9.0% below the high and 44.4% above the low.

At a market capitalisation of 39.36B SEK, it trades at 38.7 times trailing earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 22.0, a premium of 75% for MCOV-B. It pays a dividend yielding 0.84% (it pays out 34% of its earnings), against a median of 0.66% among the dividend payers in that peer group.

Medicover reports return on equity of 14.5%, an operating margin of 7.4% and revenue up 6.0% year over year.

Its debt exceeds its cash by 1.18B EUR, a debt-to-equity ratio of 2.70. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 8 analysts cover the stock, with an average rating of Buy; their mean price target of 286.91 SEK is 10.8% above the current price. The next earnings report is expected on 10 February 2027.